• Home
  • Contact Us
  • Try it!
  • Graphs
  • Publications
  • Blog

Follow us

Recent Posts

  • NEWROAD final meeting April 28, 2026
  • Biovista Vizit New Corpus: ClinicalTrials.gov September 16, 2025
  • Biovista Vizit New Corpus: MATISSE (a SoftMining algorithm) May 13, 2025
  • Biovista Vizit New Corpus: HPO March 4, 2025
  • Biovista Vizit January 2025 Release – AOP Features January 30, 2025

Biovista Vizit

Biovista Vizit

  • Try it!
  • Graphs
  • Publications
  • Blog

Targeting the RAS system against COVID-19

June 19, 2020COVID-19, Vizit Graphs
Targeting the RAS system against COVID-19Eftychia Lekka2020-08-03T13:53:58-04:00
Targeting the RAS system against COVID-19

There is growing amount of evidence to suggest the use of pharmaceuticals that target the Renin-Angiotensin System (e.g. angiotensin 1-7, ARBs and ACE inhibitors) may be beneficial in the treatment of COVID-19. This graph shows the interconnections among these classes of drugs, and SARS-CoV-2 via key genes implicated in this pathway. mediated.

Explore the live graph.

Tags: ACE, ACE2, ANGIOTENSIN (1-7), ANGIOTENSIN I, ANGIOTENSIN II, CAPTOPRIL, COVID-19, LOSARTAN, MAS, MAS1, RENIN, SARS-COV-2

Post navigation

← Administration of vitamin D could help fight COVID-19
Adverse Event considerations for repositioning remdesivir, hydroxychloroquine, chloroquine, and interleukin (IL)-6 inhibitors in COVID-19 patients →
TROGLITAZONE VERO CELLS X-RAY COMPUTED TOMOGRAPHY TUMOR GROWTH UCHL1 PROTEIN VIRAL RELEASE FROM HOST CELL TUMOR PROGRESSION TMPRSS2 VIRUS DISEASES VGF PROTEIN TARGET LESION IDENTIFICATION ULCERATIVE COLITIS TISSUE DEVELOPMENT TAUOPATHIES TRANSLATION TP53 Uberon VASODILATION THROMBOSIS TUMOR TRANSPORT VASOCONSTRICTION THROMBOCYTOPENIA TAU UBIQUITINATION TRACHEA VASCULAR TYPE 2 DIABETES THORAX VEGFA TECFIDERA WOUND HEALING THY-1 ANTIGENS TRASTUZUMAB THROMBIN TIMELESS TGF-BETA VITAMIN D TH17 CELLS VEGF TROPISM TREPONEMA DENTICOLA VEINS

© 2026 Biovista Vizit All Rights Reserved.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}